top of page

Reproductive & Endocrine Systems

Menstrual Irregularities: Anovulation and Luteal Phase Defects

Core Principle of Menstrual Irregularities
🧷 Normal menstrual cycles require precisely orchestrated hormonal signaling: GnRH pulses → FSH/LH release → follicular development → estradiol rise → LH surge → ovulation → corpus luteum formation → progesterone secretion.
🧷 Anovulation occurs when this cascade fails at any point, preventing oocyte release and corpus luteum formation, resulting in unopposed estrogen exposure.
🧷 Luteal phase defect (LPD) represents inadequate progesterone production or action despite ovulation, causing shortened luteal phase (<10 days) or insufficient endometrial preparation.
🧷 Both conditions manifest as irregular bleeding patterns but have distinct pathophysiology and fertility implications.
Solid White Background
Normal Menstrual Physiology Review
📍 Follicular phase (variable, ~14 days): FSH stimulates follicle growth → rising estradiol → endometrial proliferation.
📍 Ovulation: Estradiol surge → positive feedback on LH → LH surge → follicle rupture within 36 hours.
📍 Luteal phase (fixed, 14±2 days): Corpus luteum secretes progesterone → endometrial secretory transformation → preparation for implantation.
📍 Without pregnancy, corpus luteum involutes → progesterone withdrawal → coordinated endometrial shedding.
📍 Board pearl: The luteal phase is the most consistent component of the cycle; variation in cycle length primarily reflects follicular phase variability.
Solid White Background
Pathophysiology of Anovulation
🔹 Anovulation results from disruption of the HPO axis at any level: hypothalamic (stress, weight loss), pituitary (prolactinoma), or ovarian (PCOS).
🔹 Without ovulation, no corpus luteum forms → no progesterone production → continuous unopposed estrogen stimulation.
🔹 Unopposed estrogen causes excessive endometrial proliferation without organized shedding, leading to irregular, unpredictable bleeding.
🔹 Chronic anovulation increases risk of endometrial hyperplasia and carcinoma due to prolonged mitogenic estrogen effects.
🔹 Board pearl: Anovulatory cycles lack the temperature rise and cervical mucus changes seen with ovulation.
Solid White Background
Clinical Patterns of Anovulatory Bleeding
Oligomenorrhea: Cycles >35 days apart due to prolonged follicular phase attempts without successful ovulation.
Metrorrhagia: Irregular bleeding between expected periods from breakthrough bleeding of unstable endometrium.
Menorrhagia: Heavy bleeding when endometrium finally sheds after prolonged proliferation.
Amenorrhea: Complete absence of bleeding when estrogen levels are insufficient to stimulate any endometrial growth.
Board distinction: Regular heavy bleeding suggests anatomic causes; irregular heavy bleeding suggests anovulation.
Solid White Background
PCOS as the Prototype Anovulatory Disorder
PCOS affects 6-10% of reproductive-age women, making it the most common cause of anovulatory infertility.
Pathophysiology: Insulin resistance → hyperinsulinemia → ovarian androgen production → disrupted folliculogenesis → multiple small follicles ("string of pearls") without dominant follicle selection.
Rotterdam criteria (2/3): oligoovulation, clinical/biochemical hyperandrogenism, polycystic ovaries on ultrasound.
Metabolic consequences: insulin resistance, type 2 diabetes, dyslipidemia, metabolic syndrome.
Board pearl: PCOS patients have increased LH:FSH ratio (typically >2:1) due to increased GnRH pulse frequency.
Solid White Background
Hypothalamic Anovulation
🧠 Functional hypothalamic amenorrhea results from suppressed GnRH pulsatility due to energy deficit, stress, or excessive exercise.
🧠 The female athlete triad: disordered eating, amenorrhea, osteoporosis — all stemming from relative energy deficiency.
🧠 Mechanism: Low leptin from decreased body fat → reduced kisspeptin → suppressed GnRH pulses → low FSH/LH → hypogonadotropic hypogonadism.
🧠 Laboratory findings: Low FSH, LH, estradiol; normal prolactin and TSH.
🧠 Board clue: Young woman with BMI <18.5, amenorrhea, and stress fractures → functional hypothalamic amenorrhea with bone loss.
Solid White Background
Hyperprolactinemia and Anovulation
Prolactin directly inhibits GnRH pulsatility, causing oligomenorrhea or amenorrhea even with mild elevations.
Causes: prolactinoma (most common), medications (antipsychotics, metoclopramide), hypothyroidism, renal failure, chest wall stimulation.
Clinical triad: amenorrhea, galactorrhea, infertility — though all three present in <50% of cases.
Prolactin >100 ng/mL suggests prolactinoma; >200 ng/mL is virtually diagnostic.
Board pearl: Always check pregnancy test, TSH, and prolactin in any woman with amenorrhea — these are the three "can't miss" diagnoses.
Solid White Background
Luteal Phase Defect Pathophysiology
📌 LPD results from inadequate corpus luteum function despite successful ovulation, causing insufficient progesterone to maintain early pregnancy.
📌 Causes: subtle HPO axis dysfunction, hyperprolactinemia, thyroid disorders, elevated stress/exercise, extremes of BMI.
📌 Diagnosis historically required endometrial biopsy showing >2-day lag in histologic dating, but this is no longer recommended.
📌 Modern diagnosis: luteal phase <10 days or mid-luteal progesterone <10 ng/mL.
📌 Board distinction: LPD causes recurrent early miscarriage (6-8 weeks), while anovulation prevents conception entirely.
Solid White Background
Clinical Presentation of Luteal Phase Defect
📣 Short cycles (21-25 days) due to abbreviated luteal phase with normal follicular phase.
📣 Premenstrual spotting 2-3 days before full menstruation from early progesterone withdrawal.
📣 Recurrent first-trimester miscarriages, typically before 8 weeks when placental progesterone production should take over.
📣 Infertility despite regular cycles and confirmed ovulation.
📣 Board pearl: A woman with regular 24-day cycles and recurrent early miscarriages likely has LPD, not anovulation.
Solid White Background
Diagnostic Evaluation of Irregular Bleeding
🔸 History: cycle pattern, associated symptoms (hirsutism, galactorrhea), medications, weight changes, exercise patterns.
🔸 Initial labs: β-hCG, CBC, TSH, prolactin — the essential screening tests.
🔸 If anovulation suspected: FSH, LH, estradiol, testosterone, DHEAS, 17-hydroxyprogesterone.
🔸 Ovulation confirmation: mid-luteal progesterone >3 ng/mL confirms ovulation occurred.
🔸 Imaging: transvaginal ultrasound for PCOS morphology or structural abnormalities; MRI for suspected prolactinoma.
🔸 Board pearl: Day 21 progesterone in a 28-day cycle assesses ovulation; timing must be adjusted for different cycle lengths.
Solid White Background
Age-Specific Considerations
🧷 Adolescents: Anovulation is physiologic for 2 years post-menarche due to immature HPO axis; intervention only if bleeding is dangerous.
🧷 Reproductive age: Full evaluation warranted after 3 months of irregularity; earlier if attempting conception.
🧷 Perimenopause: Increasingly anovulatory cycles with shorter follicular phase and luteal phase defects are normal aging phenomena.
🧷 Board pearl: Irregular bleeding in the first 2 years after menarche or the 5 years before menopause is usually physiologic.
Solid White Background
Endometrial Effects of Chronic Anovulation
📍 Unopposed estrogen → simple hyperplasia → complex hyperplasia → atypical hyperplasia → endometrial carcinoma.
📍 Risk increases with duration and degree of estrogen exposure without progesterone opposition.
📍 Annual risk of progression: simple hyperplasia (1%), complex hyperplasia (3%), atypical hyperplasia (8-29%).
📍 Protective factors: anything that provides progesterone (pregnancy, combined OCs, cyclic progestins).
📍 Board pearl: Any woman with >3 months of amenorrhea needs progesterone challenge or endometrial protection.
Solid White Background
Treatment of Anovulation — Non-Fertility Goals
🔹 Combined oral contraceptives: provide cyclic hormone exposure, prevent endometrial hyperplasia, regulate bleeding pattern.
🔹 Cyclic progestins: medroxyprogesterone acetate 10 mg daily × 10-14 days/month induces withdrawal bleeds and protects endometrium.
🔹 Metformin for PCOS: improves insulin sensitivity → reduces androgens → may restore ovulation in 40-50%.
🔹 Weight optimization: 5-10% weight loss in PCOS or weight gain in hypothalamic amenorrhea can restore cycles.
🔹 Board pearl: Progestin-only contraception may worsen irregular bleeding; combined formulations are preferred for cycle control.
Solid White Background
Ovulation Induction Strategies
Clomiphene citrate: selective estrogen receptor modulator → blocks hypothalamic feedback → increased FSH → follicle development. First-line for PCOS.
Letrozole: aromatase inhibitor → reduced estrogen → increased FSH. May be superior to clomiphene for PCOS.
Gonadotropins: direct FSH/LH administration for women who fail oral agents; requires close monitoring for multiple gestation.
Pulsatile GnRH: physiologic approach for hypothalamic amenorrhea; requires pump but avoids ovarian hyperstimulation.
Board pearl: Clomiphene can cause hot flashes and visual changes; letrozole avoids anti-estrogenic side effects.
Solid White Background
Treatment of Luteal Phase Defect
Progesterone supplementation: vaginal progesterone 200 mg twice daily starting 3 days after ovulation through first trimester.
Treatment of underlying causes: normalize prolactin, correct thyroid dysfunction, optimize weight/stress.
Clomiphene or letrozole: enhance follicular development → better corpus luteum function → improved progesterone production.
HCG injections: directly stimulate corpus luteum but risk ovarian hyperstimulation.
Board distinction: LPD treatment focuses on progesterone support; anovulation treatment focuses on inducing ovulation.
Solid White Background
Complications and Long-Term Risks
🧠 Infertility: anovulation accounts for 25% of female infertility; LPD accounts for 3-10%.
🧠 Endometrial cancer: relative risk 2-3× higher with chronic anovulation, especially if obese.
🧠 Metabolic syndrome: PCOS patients have increased risk of diabetes, hypertension, dyslipidemia.
🧠 Osteoporosis: hypoestrogenic states (functional hypothalamic amenorrhea) cause rapid bone loss.
🧠 Cardiovascular disease: both PCOS and prolonged hypoestrogenism increase long-term cardiovascular risk.
Solid White Background
Special Testing Considerations
Progesterone challenge test: 10 mg medroxyprogesterone × 10 days; withdrawal bleeding confirms adequate estrogen and patent outflow tract.
No withdrawal bleeding suggests: pregnancy, outflow obstruction, or hypoestrogenic state requiring further evaluation.
Basal body temperature charting: 0.5°F rise after ovulation from progesterone thermogenic effect; labor-intensive but cheap.
Ovulation predictor kits: detect LH surge 24-36 hours before ovulation; useful for timing but don't confirm ovulation occurred.
Board pearl: Progesterone >3 ng/mL confirms ovulation; >10 ng/mL suggests adequate luteal function.
Solid White Background
Differential Diagnosis Pitfalls
📌 Pregnancy: always the first consideration in any reproductive-age woman with irregular bleeding.
📌 Thyroid disease: both hyper- and hypothyroidism cause menstrual irregularities through multiple mechanisms.
📌 Bleeding disorders: von Willebrand disease presents as heavy regular periods from menarche, not irregular cycles.
📌 Anatomic causes: polyps, fibroids cause regular heavy bleeding; anovulation causes irregular unpredictable bleeding.
📌 Board clue: Heavy bleeding since menarche → coagulopathy; heavy bleeding developing later → structural or hormonal.
Solid White Background
Board Question Stem Patterns
📣 16-year-old with irregular periods since menarche 18 months ago → physiologic anovulation, reassurance.
📣 28-year-old with BMI 32, hirsutism, 3 periods/year → PCOS, check testosterone and glucose tolerance.
📣 24-year-old marathon runner with amenorrhea and stress fracture → functional hypothalamic amenorrhea, needs estrogen.
📣 32-year-old with regular 24-day cycles and 3 early miscarriages → luteal phase defect, supplement progesterone.
📣 35-year-old with 4 months amenorrhea after stopping OCs → post-pill amenorrhea, check prolactin and TSH.
📣 Galactorrhea + amenorrhea + headaches → prolactinoma, check prolactin and MRI.
📣 Irregular bleeding + unopposed estrogen × 5 years → endometrial biopsy to exclude hyperplasia/cancer.
Solid White Background
One-Line Recap
🔸 Menstrual irregularities divide into anovulation (absent ovulation causing unopposed estrogen and unpredictable bleeding, commonly from PCOS or hypothalamic suppression) and luteal phase defects (inadequate progesterone despite ovulation causing short cycles and early miscarriage), with diagnosis via cycle tracking and mid-luteal progesterone, and treatment ranging from hormonal regulation to ovulation induction based on fertility goals.
Solid White Background
bottom of page